{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:28:18Z","timestamp":1784824098091,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.intimp.2022.109152","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T13:37:32Z","timestamp":1661175452000},"page":"109152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Mesenchymal stem cell transplantation alleviates Sj\u00f6gren's syndrome symptoms by modulating Tim-3 expression"],"prefix":"10.1016","volume":"111","author":[{"given":"Tian","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zutong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.109152_b0005","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/jama.2009.1254","article-title":"Kelley\u2019s textbook of rheumatology","volume":"302","author":"Ehrlich","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2022.109152_b0010","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sjogren's syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2022.109152_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020658","article-title":"The involvement of innate and adaptive immunity in the initiation and perpetuation of Sjogren's syndrome","volume":"22","author":"Chivasso","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2022.109152_b0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1586\/1744666X.2014.878650","article-title":"Dendritic cells, T-cells and epithelial cells: a crucial interplay in immunopathology of primary Sjogren's syndrome","volume":"10","author":"Hillen","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.intimp.2022.109152_b0025","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00018-017-2473-5","article-title":"Interactions between mesenchymal stem cells and the immune system","volume":"74","author":"Li","year":"2017","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2022.109152_b0030","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-020-01837-x","article-title":"Mesenchymal stem cells inhibited the differentiation of MDSCs via COX2\/PGE2 in experimental sialadenitis","volume":"11","author":"Qi","year":"2020","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2022.109152_b0035","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-021-01037-x","article-title":"Challenges and advances in clinical applications of mesenchymal stromal cells","volume":"14","author":"Zhou","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2022.109152_b0040","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13287-021-02236-6","article-title":"Secreted factors from dental pulp stem cells improve Sjogren's syndrome via regulatory T cell-mediated immunosuppression","volume":"12","author":"Matsumura-Kawashima","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.intimp.2022.109152_b0045","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","article-title":"Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome","volume":"120","author":"Xu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2022.109152_b0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.revmed.2019.09.005","article-title":"Immune-related adverse events after immune checkpoints inhibitors in 2019: an update","volume":"41","author":"Comont","year":"2020","journal-title":"Rev. Med. Interne"},{"issue":"1","key":"10.1016\/j.intimp.2022.109152_b0055","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0645-6","article-title":"Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance","volume":"7","author":"Couey","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2022.109152_b0060","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.chest.2017.12.010","article-title":"Sjogren syndrome with associated lymphocytic interstitial pneumonia successfully treated with tacrolimus and abatacept as an alternative to rituximab","volume":"153","author":"Thompson","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.intimp.2022.109152_b0065","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3233\/CBM-210114","article-title":"Role of Tim-3 in regulating tumorigenesis, inflammation, and antitumor immunity therapy","volume":"32","author":"Cao","year":"2021","journal-title":"Cancer Biomark"},{"issue":"12","key":"10.1016\/j.intimp.2022.109152_b0070","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2022.109152_b0075","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.3390\/jcm9113563","article-title":"Serum levels of T cell immunoglobulin and mucin-domain containing molecule 3 in patients with systemic lupus erythematosus","volume":"9","author":"Asano","year":"2020","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.intimp.2022.109152_b0080","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/art.41554","article-title":"Distinct expression of coinhibitory molecules on alveolar T cells in patients with rheumatoid arthritis-associated and idiopathic inflammatory myopathy-associated interstitial lung disease","volume":"73","author":"Nakazawa","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109152_b0085","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.25682","article-title":"The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9\/tim-3 pathway","volume":"56","author":"Liberal","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.intimp.2022.109152_b0090","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-021-02527-6","article-title":"Serum checkpoint molecules in patients with IgG4-related disease (IgG4-RD)","volume":"23","author":"Matsumoto","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2022.109152_b0095","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2147\/OTT.S237222","article-title":"TIM-3 participates in the invasion and metastasis of nasopharyngeal carcinoma via SMAD7\/SMAD2\/SNAIL1 axis-mediated epithelial-mesenchymal transition","volume":"13","author":"Xiao","year":"2020","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.intimp.2022.109152_b0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/cei.13337","article-title":"Interleukin-17 and -22 synergy linking inflammation and EMT-dependent fibrosis in Sjogren's syndrome","volume":"198","author":"Sisto","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2022.109152_b0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4110\/in.2015.15.5.241","article-title":"Galectin-9 is involved in immunosuppression mediated by human bone marrow-derived clonal mesenchymal stem cells","volume":"15","author":"Kim","year":"2015","journal-title":"Immune Netw."},{"key":"10.1016\/j.intimp.2022.109152_b0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clim.2017.05.001","article-title":"What can Sjogren's syndrome-like disease in mice contribute to human Sjogren's syndrome?","volume":"182","author":"Peck","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2022.109152_b0115","first-page":"166","article-title":"Experimental models of juvenile onset (insulin-dependent) diabetes mellitus","volume":"21","author":"Craighead","year":"1980","journal-title":"Monogr. Pathol."},{"key":"10.1016\/j.intimp.2022.109152_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102611","article-title":"Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjogren's syndrome","volume":"119","author":"Kim","year":"2021","journal-title":"J. Autoimmun."},{"issue":"8","key":"10.1016\/j.intimp.2022.109152_b0125","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/art.38674","article-title":"A CD8 T cell\/indoleamine 2,3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus","volume":"66","author":"Wang","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.intimp.2022.109152_b0130","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/jcp.21.5.656","article-title":"Labial salivary gland biopsy in Sjogren's disease","volume":"21","author":"Chisholm","year":"1968","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.intimp.2022.109152_b0135","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/rheumatology\/keu316","article-title":"Umbilical cord mesenchymal stem cells inhibit the differentiation of circulating T follicular helper cells in patients with primary Sjogren's syndrome through the secretion of indoleamine 2,3-dioxygenase","volume":"54","author":"Liu","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.intimp.2022.109152_b0140","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.4049\/jimmunol.0903059","article-title":"T cell\/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells","volume":"184","author":"DeKruyff","year":"2010","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2022.109152_b0145","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.2376","article-title":"Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1","volume":"13","author":"Chiba","year":"2012","journal-title":"Nat. Immunol."},{"issue":"7534","key":"10.1016\/j.intimp.2022.109152_b0150","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature13848","article-title":"CEACAM1 regulates TIM-3-mediated tolerance and exhaustion","volume":"517","author":"Huang","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2022.109152_b0155","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jid.2021.11.031","article-title":"Type I interferons in autoimmunity","volume":"142","author":"Fernandez-Ruiz","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2022.109152_b0160","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/glia.20587","article-title":"Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro","volume":"55","author":"Carter","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2022.109152_b0165","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/art.10577","article-title":"Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjogren's syndrome","volume":"46","author":"Ogawa","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.intimp.2022.109152_b0170","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/rheumatology\/ket401","article-title":"CX3CL1 and CX3CR1 expression in tertiary lymphoid structures in salivary gland infiltrates: fractalkine contribution to lymphoid neogenesis in Sjogren's syndrome","volume":"53","author":"Astorri","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2022.109152_b0175","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.4049\/jimmunol.180.7.4409","article-title":"Lack of TIM-3 immunoregulation in multiple sclerosis","volume":"180","author":"Yang","year":"2008","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109152_b0180","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/eji.200939842","article-title":"T-bet, a Th1 transcription factor regulates the expression of Tim-3","volume":"40","author":"Anderson","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109152_b0185","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ni.2046","article-title":"Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection","volume":"12","author":"Kao","year":"2011","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109152_b0190","article-title":"An IL-27\/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction","volume":"6","author":"Zhu","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2022.109152_b0195","article-title":"Targeting STAT3 abrogates Tim-3 upregulation of adaptive resistance to PD-1 blockade on regulatory T cells of melanoma","volume":"12","author":"Huang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.109152_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.05.048","article-title":"Extracellular vesicles from mesenchymal stem cells prevent contact hypersensitivity through the suppression of Tc1 and Th1 cells and expansion of regulatory T cells","volume":"74","author":"Guo","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2022.109152_b0205","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41419-020-03034-3","article-title":"Mesenchymal stem cells reverse EMT process through blocking the activation of NF-kappaB and Hedgehog pathways in LPS-induced acute lung injury","volume":"11","author":"Xiao","year":"2020","journal-title":"Cell Death Dis"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922006361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922006361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:51:35Z","timestamp":1761587495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922006361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":41,"alternative-id":["S1567576922006361"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109152","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stem cell transplantation alleviates Sj\u00f6gren's syndrome symptoms by modulating Tim-3 expression","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109152"}}